Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study

Transplantation. 2011 May 27;91(10):e72-3. doi: 10.1097/TP.0b013e318216c1db.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Cyclosporine / administration & dosage*
  • Cyclosporine / adverse effects
  • Drug Therapy, Combination
  • Everolimus
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control*
  • Graft Survival / drug effects*
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / adverse effects
  • Kidney Transplantation* / immunology
  • Sirolimus / administration & dosage
  • Sirolimus / adverse effects
  • Sirolimus / analogs & derivatives*
  • Time Factors
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Everolimus
  • Sirolimus